Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the ...

Sanofi and Regeneron have announced that dupilumab has received FDA approval as an add-on maintenance treatment for adults ...

A study has revealed triptans are the most effective medicine for adults experiencing acute migraine. Read more ...

Discover an automated speech analysis platform that has been developed to test for minimal hepatic encephalopathy (HE) and to ...

A study from Memorial Sloan Kettering identifies a 6% risk of second primary malignancies in CAR T-cell therapy patients for ...

A study highlights that GLP-1 RAs are linked to a reduced risk of cirrhosis in patients with MASLD and diabetes. Learn more ...

Discover the potential of chemokines as biomarkers that could enhance the diagnosis and bleeding evaluation in patients with ...

Research from SPIN confirms COVID-19 vaccines are safe for systemic sclerosis patients, with most reporting no severe side ...

ESD is a proven, safe treatment for high-risk colorectal neoplasia in IBD patients, offering high success rates and minimal ...

A study reveals frailty, rather than chronological age, as a stronger predictor of severe infections in older adults with ANCA-associated vasculitis.

Research suggests that higher serum anti-PD-1 autoantibody levels in HCC patients undergoing Atezo/Bev therapy are linked to ...

Over half of healthy U.S. infants contract RSV in their first year, according to a Vanderbilt University Medical Center study ...